Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
In 1969, the anticancer effect of CP was evaluated in the sarcoma mouse model (Rosenberg et al., 1969), and by 1971, CP had entered phase I clinical trials and was finally approved by the US Food and Drug Administration for the management of cancers in 1978 ( It is currently well established that CP mediates its tumoricidal effects through binding to DNA, causing formation of intra- and interstrand cross-links
This causes the immune system to make substances that cause the symptoms of illness, like brain fog, appetite loss, and reduced interest in your favorite activities
Le Rhun E, Preusser M, Roth P, Reardon DA, van den Bent M, Wen P, et al
Like many research peptides, Thymalin should only be used within properly controlled laboratory environments
Some patients may not be appropriate candidates based on active conditions, medication use, or other medical factors
Doctors often choose FDA-approved options from reliable manufacturers like Novo Nordisk to ensure their patients get quality and safe medication
